Loading...
7 Agonists Reports
Study Period: 2018 - 2029
Countries Covered: Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam
Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.
Study Period: 2019 - 2029
Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia
Major Players: Novo Nordisk, AstraZeneca, Eli lilly and Company, Sanofi, Pfizer
Study Period: 2018 - 2029
Countries Covered: United States, Canada
Major Players: Astrazeneca, Sanofi, Eli Lilly and Company, Pfizer Inc., Novo Nordisk A/S
Study Period: 2019- 2029
Regions Covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.
Study Period: 2019- 2029
Countries Covered: Saudi Arabia, Egypt, Iran, South Africa, Oman
Major Players: AstraZeneca, Sanofi, Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc.
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific
Major Players: Sanofi Aventis , Mallinckrodt Pharmaceuticals, Pfizer Inc, Novartis (Sandoz Canada Inc.) , Epic Pharma
Study Period: 2019 - 2029
Countries Covered: Brazil, Mexico
Major Players: AstraZeneca, Biocon, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Filter Reports
By Region
By Countries
